143 related articles for article (PubMed ID: 8761334)
1. Peripheral cells as an investigational tool for Alzheimer's disease.
Govoni S; Gasparini L; Racchi M; Trabucchi M
Life Sci; 1996; 59(5-6):461-8. PubMed ID: 8761334
[TBL] [Abstract][Full Text] [Related]
2. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease.
Gasparini L; Racchi M; Binetti G; Trabucchi M; Solerte SB; Alkon D; Etcheberrigaray R; Gibson G; Blass J; Paoletti R; Govoni S
FASEB J; 1998 Jan; 12(1):17-34. PubMed ID: 9438407
[TBL] [Abstract][Full Text] [Related]
3. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.
Gibson G; Martins R; Blass J; Gandy S
Life Sci; 1996; 59(5-6):477-89. PubMed ID: 8761336
[TBL] [Abstract][Full Text] [Related]
4. Testing pathophysiological hypotheses of Alzheimer's disease and pharmacological modulation of amyloid precursor protein metabolism: the contribution from the studies on cultured fibroblasts from affected donors.
Racchi M; Gasparini L; Trabucchi M; Govoni S
Aging (Milano); 1997; 9(4 Suppl):57-8. PubMed ID: 9358886
[No Abstract] [Full Text] [Related]
5. Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease.
Eckert A; Förstl H; Zerfass R; Hartmann H; Müller WE
Life Sci; 1996; 59(5-6):499-510. PubMed ID: 8761338
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities.
Pascale A; Etcheberrigaray R
Pharmacol Res; 1999 Feb; 39(2):81-8. PubMed ID: 10072697
[TBL] [Abstract][Full Text] [Related]
8. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
[TBL] [Abstract][Full Text] [Related]
9. Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts.
Gasparini L; Benussi L; Bianchetti A; Binetti G; Curti D; Govoni S; Moraschi S; Racchi M; Trabucchi M
Neurosci Lett; 1999 Mar; 263(2-3):197-200. PubMed ID: 10213169
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
Neve RL; McPhie DL; Chen Y
Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals.
Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B
Neurochem Res; 2001 Jul; 26(7):817-20. PubMed ID: 11565613
[TBL] [Abstract][Full Text] [Related]
13. Calnuc binds to Alzheimer's beta-amyloid precursor protein and affects its biogenesis.
Lin P; Li F; Zhang YW; Huang H; Tong G; Farquhar MG; Xu H
J Neurochem; 2007 Mar; 100(6):1505-14. PubMed ID: 17348862
[TBL] [Abstract][Full Text] [Related]
14. [Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease].
Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B
Ideggyogy Sz; 2002 May; 55(5-6):164-7. PubMed ID: 12122875
[TBL] [Abstract][Full Text] [Related]
15. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
16. beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.
Barger SW; Smith-Swintosky VL; Rydel RE; Mattson MP
Ann N Y Acad Sci; 1993 Sep; 695():158-64. PubMed ID: 8239276
[TBL] [Abstract][Full Text] [Related]
17. The cultured fibroblast model.
Blass JP
J Neural Transm Suppl; 1994; 44():87-95. PubMed ID: 7897402
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease.
Tatebayashi Y; Takeda M; Kashiwagi Y; Okochi M; Kurumadani T; Sekiyama A; Kanayama G; Hariguchi S; Nishimura T
Dementia; 1995; 6(1):9-16. PubMed ID: 7728221
[TBL] [Abstract][Full Text] [Related]
19. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
20. Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts.
Bergamaschi S; Binetti G; Govoni S; Wetsel WC; Battaini F; Trabucchi M; Bianchetti A; Racchi M
Neurosci Lett; 1995 Dec; 201(1):1-5. PubMed ID: 8830300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
